Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2022 Sep 14.
Published in final edited form as: Anal Chem. 2021 Aug 30;93(36):12374–12382. doi: 10.1021/acs.analchem.1c02224

Comparison of High-Resolution Fourier Transform Mass Spectrometry Platforms for Putative Metabolite Annotation

Danning Huang 1, Marcos Bouza 2, David A Gaul 3, Franklin E Leach III 4, I Jonathan Amster 5, Frank C Schroeder 6, Arthur S Edison 7, Facundo M Fernández 8
PMCID: PMC8590398  NIHMSID: NIHMS1752619  PMID: 34460220

Abstract

Fourier transform ion cyclotron resonance (FTICR) and Orbitrap mass spectrometry (MS) are among the highest-performing analytical platforms used in metabolomics. Non-targeted metabolomics experiments, however, yield extremely complex datasets that make metabolite annotation very challenging and sometimes impossible. The high-resolution accurate mass measurements of the leading MS platforms greatly facilitate this process by reducing mass errors and spectral overlaps. When high resolution is combined with relative isotopic abundance (RIA) measurements, heuristic rules, and constraints during searches, the number of candidate elemental formula(s) can be significantly reduced. Here, we evaluate the performance of Orbitrap ID-X and 12T solariX FT-ICR mass spectrometers in terms of mass accuracy and RIA measurements and how these factors affect the assignment of the correct elemental formulas in the metabolite annotation pipeline. Quality of the mass measurements was evaluated under various experimental conditions (resolution: 120, 240, 500 K; automatic gain control: 5 × 104, 1 × 105, 5 × 105) for the Orbitrap MS platform. High average mass accuracy (<1 ppm for UPLC-Orbitrap MS and <0.2 ppm for direct infusion FT-ICR MS) was achieved and allowed the assignment of correct elemental formulas for over 90% (m/z 75–466) of the 104 investigated metabolites. 13C1 and 18O1 RIA measurements further improved annotation certainty by reducing the number of candidates. Overall, our study provides a systematic evaluation for two leading Fourier transform (FT)-based MS platforms utilized in metabolite annotation and provides the basis for applying these, individually or in combination, to metabolomics studies of biological systems.

Graphical Abstract

graphic file with name nihms-1752619-f0001.jpg


Non-targeted metabolomics studies yield extremely complex datasets due to their comprehensive nature. When mass spectrometry (MS) analytical platforms are used, hundreds to thousands of endogenous metabolites can be detected in biological samples owing to this platform’s high sensitivity.1 As the data are collected without a predefined list of target metabolites, the confident annotation of selected species is a prerequisite step to a robust biological interpretation of the results. However, annotation is currently recognized as the major bottleneck in non-targeted metabolomics studies due to the wide structural diversity of metabolites2 and because the majority of small molecule structures in biological systems are still unknown.

Unlike proteins and nucleic acids, which are derived from a well-defined set of building blocks (e.g., amino acid, nucleobases) and can therefore be sequenced, biogenic small molecules may incorporate building blocks from many metabolic pathways and can be further transformed through a number of routes. The existence of structural and stereoisomers adds additional complexity to the metabolome. Though a number of databases that contain large lists of endogenous metabolites in biological systems are available for searching, such as the Human Metabolome Database (HMDB),3 METLIN,4 mzCloud (https://www.mzcloud.org), LIPID MAPS,5 LipidBlast,6 National Institute of Standards and Technology (NIST) library (http://chemdata.nist.gov), etc., their coverage is still largely incomplete.2

The process of metabolite annotation is typically started by searching experimental mass measurements against databases with a certain mass tolerance window to obtain potential candidate elemental formulas. These putative metabolite annotations are then refined by matching orthogonal information (e.g., tandem mass spectrometry (MS/MS) fragmentation information,7 retention time, collision cross section (CCS),8 drift time,9 etc.). Using more than one type of supporting orthogonal information is preferable to increase the confidence in the annotations.10 Assignments are ultimately validated by matching pure reference chemical standards under identical experimental conditions, if available. The initial assignment of accurate elemental formulas is, therefore, of central importance for metabolite annotation. High-resolution mass measurements greatly facilitate elemental formula assignments by reducing mass errors and spectral overlaps. When applied together with heuristic rules, analysis of isotope abundance pattern, and constraints during searches (e.g., hydrogen/carbon ratios, ring double bond equivalents (RDBE) restrictions, elemental ratios of nitrogen, oxygen, phosphorous, and sulfur vs. carbon, etc.),11,12 the number of candidate elemental formulas found can be significantly reduced, greatly simplifying the process.

Currently, Fourier transform ion cyclotron resonance (FTICR) MS13 and Orbitrap MS14 are among the highest-performing analytical MS platforms in metabolomics.15,16 Both employ a Fourier transform to determine the frequency of ion motion in confining magnetic and/or electric fields followed by mass calibration and thus are referred to as Fourier transform-based mass spectrometry (FTMS).17 The inherent high fidelity of FTMS in the determination of ion motion frequency allows very high mass accuracy and resolving power, enabling a highly detailed investigation of biological metabolomes.15,16 The latest generation of Orbitrap instruments is able to achieve mass resolution up to 1 M full width at half maximum (FWHM) at m/z 200 and mass accuracies better than 1 ppm,18 whereas FT-ICR mass spectrometers can achieve maximum resolving power >10 M and mass accuracy better than 0.2 ppm.19 However, high mass accuracy alone is not sufficient for determining the most likely elemental formula. Even with <1 ppm mass accuracy, the number of potential elemental formula candidates increases with increasing of m/z.20 Therefore, additional information is needed to further reduce the number of possible assignments and improve annotation confidence. For example, Kind and Fiehn found that mass spectrometers capable of 3 ppm mass accuracy with 2% error in the isotopic abundance patterns outperformed mass spectrometers with <1 ppm mass accuracy alone in determining correct elemental formulas.20 It is now generally accepted that relative isotopic abundance (RIA) of stable elemental isotopes such as 13C, 18O, 15N, and 34S is highly informative for the correct assignment of elemental formulas, as it can be used to estimate the number of various atoms present in the composition of a given metabolite. Ultrahigh resolution is a desirable feature for accurate RIA measurements, as it helps to reduce spectral overlap, producing isotopic clusters free from spectral interferences. For example, FT-ICR MS has been shown to be capable of distinguishing CHONPS elemental isotopes and unambiguously determining molecular formulas.21,22

Though FT-ICR MS has unparalleled high resolving power, its main disadvantage is the relatively slow acquisition rate and lack of automatic gain control (AGC), somewhat limiting its application to liquid chromatography-mass spectrometry (LC-MS)-based metabolomics.16 As a result, FT-ICR MS in direct infusion mode (DI-MS) is typically favored over LC FT-ICR MS approaches.15,16,21 However, the recent implementation of absorption mode and ICR signal detection at the high order harmonic frequencies have enabled faster acquisition rates,23,24 leading to even more successful applications in non-targeted metabolomics.21,2527

Together with time-of-flight instrumentation, Orbitrap MS coupled with LC is perhaps one of the most widely used metabolomics platforms due to its high mass resolution, mass accuracy, and sensitivity, with high-field Orbitrap analyzers having scan rates readily compatible with ultra performance liquid chromatography (UPLC).16,2830

To date, a number of studies have been conducted to evaluate the performance of FTMS in terms of metabolite annotation. For example, Knolhoff et al. compared the mass accuracy and RIA between Orbitrap and quadrupole-time-of-flight (Q-TOF) mass spectrometers.31 Xu et al. evaluated accurate mass measurements and RIA of linear ion trap quadrupole (LTQ)-Orbitrap MS,32 and Barbier Saint Hilaire et al. evaluated the performance of the Orbitrap Fusion mass spectrometer by accurately measuring masses and RIA for metabolite annotation purposes.33 Mitchell et al. developed a method for determining elemental formulas using detected sets of isotopic peaks from spectra generated by FTMS platforms.34 Thompson et al. developed a flow injection (FI) continuous accumulation of selected ions (CASI) FT-ICR MS workflow to reveal isotopic fine structures and better assign elemental formulas.35 In addition, Weber et al. characterized the accuracy of RIA measurements of two FTMS platforms, LTQ FT-ICR MS and LTQ Orbitrap MS, for elemental formula assignment.36 Those studies provided valuable insights into the performance of leading FTMS analytical platforms in the metabolomics field at the time of publication.

In this study, we evaluate the mass and 13C and 18O RIA measurement accuracies produced by high-field Orbitrap ID-X and 12T solariX FT-ICR platforms and investigate how these affect the assignment of the correct elemental formulas in metabolite annotation applications. For Orbitrap MS, we assessed the performance at different resolution and automatic gain control (AGC) settings. Mixtures containing 104 small molecular weight metabolites (m/z 75–620) in model solutions and complex Caenorhabditis elegans biological matrices were used for the experiments. DI-FT-ICR MS and UPLC-Orbitrap MS workflows were developed to evaluate the performance of the platforms under optimized conditions. To the best of our knowledge, this is the first report systematically evaluating the performance of two of the highest-performing FTMS platforms at the present time in a metabolomics context.

EXPERIMENTAL SECTION

Sample Preparation.

One hundred and four selected chemical standard compounds were purchased from Sigma-Aldrich (St. Louis, MO) and used to prepare stock solutions at a concentration of 0.001 M in LC-MS grade methanol (Fisher Scientific, Pittsburgh, PA). These standards were selected because they map to key metabolic pathways, some altered in cancer.37 The list of standard compounds used is provided in the Supporting Information section (Table S1). If a chemical could not be completely dissolved in methanol, LC-MS grade water (Fisher Scientific, Pittsburgh, PA) was added to increase the solubility. A pooled sample of 104 standard compounds was diluted with methanol at a final concentration of 5 μM.

Three-2.0 mm zirconium oxide beads and ~75 μL of 0.5 mm glass beads were added to each lyophilized PD1074 C. elegans sample (~10 mg). Samples were placed in a TissueLyser II (QIAGEN, Hilden, Germany) and homogenized at 1800 rpm, at 80 °C for 3 min. One and a half milliliter of 80% methanol (in water) was added to each homogenized sample. Samples were then shaken using an Isotemp high-speed shaker (Fisher Scientific, Pittsburgh, PA) at 1500 rpm for 30 min, and centrifuged at 22 100g for 5 min. The supernatant was collected, dried, and stored at −80 °C. Prior to MS analysis, dried C. elegans matrices were resuspended with 1 mL LC-MS grade methanol containing the 104 standard compounds at a 5 μM concentration.

FTMS Analysis.

Samples were subjected to DI-MS analysis on a 12T solariX FT-ICR mass spectrometer equipped with a Paracell (Bruker, Bremen, Germany) and UPLC-MS analysis on an Orbitrap ID-X mass spectrometer (Thermo Fisher Scientific, Waltham, MA) in both positive and negative ion modes. For UPLC-Orbitrap MS analysis, liquid chromatography was performed with an Acquity UPLC BEH Amide, 2.1 × 150 mm2, 1.7 μm-particle column on a Vanquish UPLC system (Thermo Fisher Scientific, Waltham, MA). Mobile phase A was water/acetonitrile (80:20 v/v), 10 mM ammonium formate, and 0.1% formic acid. Mobile phase B was acetonitrile with 0.1% formic acid. All solvents and additives used to prepare mobile phases were LC-MS grade and purchased from Fisher Chemical (Pittsburgh, PA). The gradient program used for chromatographic separation can be found in the Supporting Information section (Table S2). The column temperature was 40 °C, while samples were maintained at 4 °C in the autosampler. The injection volume was 2 μL. The spray voltages were 3.5 and −2.5 kV in positive and negative ion modes, respectively. In both modes, various combinations of resolution settings (120, 240, and 500 K) and AGC target values (5 × 104, 1 × 105, 5 × 105) were used in data acquisition. The instrument was externally calibrated with a Pierce FlexMix calibration solution (Thermo Fisher Scientific, Waltham, MA), and the internal calibration feature (EASY-IC) was turned on.

For DI-FT-ICR MS analysis, samples were introduced to the ion source through a syringe pump at a 4.0 μL min−1 flow rate (total sample volume consumed: ~32 μL per 8.35 min DI-MS analysis). MS acquisition parameters in both positive and negative ion modes can be found in the Supporting Information (Table S3). A spectral size of 8 M was used for data acquisition with an ion accumulation time of 0.025 s and a scan range of 73.71–1000.00 m/z. Before data acquisition, the instrument was externally calibrated with 0.1 mg mL−1 sodium trifluoroacetate (NaTFA) in water/acetonitrile (50:50 v/v). Each sample was run in triplicate. CASI experiments were also attempted; however, no significant performance improvements were observed and were therefore not further pursued.

Data Processing.

Following data acquisition, MZmine 2.5138,39 was used for preprocessing of profile data generated from UPLC-Orbitrap MS and DI-FT-ICR MS analyses. Raw data generated from the FT-ICR platform was converted to mzML files using msConvert40 prior to importing into MZmine. The procedure included peak picking, chromatogram deconvolution, and peak area integration. The parameters for processing the raw data collected from Orbitrap MS and FT-ICR MS can be found in the Supporting Information. For all of the datasets, mass errors were calculated and used to assign elemental formulas (mass error tolerance: <0.001 m/z or 3.0 ppm) with [C0–50H0–100N0–15O0–20P0–7S0–8 ± H]± limits, heuristic rules, and RDBE restrictions applied through the MZmine built-in functions (Supporting Information).11 RIA errors and the number of elemental atoms were calculated using eqs 1 and 2, respectively

RIAerror=RIAexp.RIAtheo.RIAtheo.×100% (1)
no.atoms=RIAexp.relativeabu. (2)

where exp. stands for experimental, theo. stands for theoretical, and abu. stands for abundance (13C: 1.1%, 18O: 0.2%).

A three-step filtering approach was used for assigning elemental formulas for every investigated m/z value: (1) Assign candidate elemental formulas solely by mass accuracy using the built-in formula prediction function in MZmine. (2) Calculate the number of carbon atoms based on 13C RIA and then use the no.Cexp ± 1 to filter elemental formula candidates. (3) Calculate the number of oxygen atoms based on 18O RIA and use the no.Oexp ± 1 to further filter elemental formula candidates.

Data generated in this work are available through the NIH Metabolomics Workbench (http://www.metabolomicsworkbench.org/) with project ID PR001131 and doi: 10.21228/M8HD7B (Orbitrap MS, study ID: ST001777 and FT-ICR MS, study ID: ST001778).

RESULTS AND DISCUSSION

Mass Accuracy Evaluation.

A pooled sample containing 104 metabolite standards in methanol, with m/z values ranging from 75 to 620, was analyzed using both DI-FT-ICR MS and UPLC-Orbitrap MS. Pairs of retention time and monoisotopic accurate masses measured for individual standards were used to identify the metabolites in the mixture. The impact of different resolution and AGC target settings on mass accuracy was investigated for the UPLC-Orbitrap MS platform and compared with the DI-FT-ICR MS platform. The number of metabolites species detected and their corresponding mass accuracy for different settings are shown in Table 1.

Table 1.

Average Mass Accuracy for Metabolite Monoisotopic Ions Detected in a Model Mixture under Various Experimental Conditions

Average Mass Error (ppm)a Number of Metabolites Detected (out of 104)d
AGC╲Rb 120
K
240
K
500
K
AGC╲R 120
K
240
K
500
K
Pos.
Mode
5e4 0.34 0.41 0.46 5e4 74 72 72
1e5 0.29 0.33 0.37 1e5 73 72 70
5e5 0.33 0.36 0.35 5e5 72 71 65
FT-ICRc 0.10 FT-ICR 75
Neg.
Mode
5e4 0.36 0.31 0.29 5e4 88 83 78
1e5 0.37 0.32 0.36 1e5 87 82 75
5e5 0.69 0.71 0.88 5e5 82 75 71
FT-ICR 0.11 FT-ICR 93
a

The mass error was calculated as the mean absolute error for all detected species.

b

R: mass resolution (defined as FWHM at m/z 200), AGC: automatic gain control target, both settings were for the Orbitrap platform.

c

For the FT-ICR MS platform, a spectral size of 8 M (~700 K mass resolution at m/z 200) and 0.025 s ion accumulation time were used for data acquisition. Pos.: positive, neg.: negative.

d

For the Orbitrap MS platform, 45–62 overlapping species were detected in both modes; the highest number (62) were detected at a resolution setting of 120 K with an AGC target value of 5 × 104 and the lowest number of overlapping species (45) were detected at a resolution setting of 500 K with an AGC target value of 5 × 105. For the FT-ICR MS platform, a total of 65 species were detected in both ion modes.

As expected, metabolite standards exhibited a wide range of ionization efficiencies in the different ionization modes tested. For the Orbitrap platform, 65–74 species were detected in positive ion mode and 71–88 species were detected in negative ion mode, with 45–62 species overlapping between both modes. A lower number of metabolites were detected when resolution and/or AGC target values were increased in Orbitrap experiments. The lowest number of metabolites—65 and 71 species in positive and negative modes, respectively—were detected at a resolution setting of 500 K with an AGC target value of 5 × 105 (Table 1). These ion losses were attributed to the lower scan speeds at the highest resolving power setting and the increased ion filling at high AGC target values that results in lower abundance ion species becoming undetectable.41 In addition, the resolution and AGC target settings also affected the detected overall peak abundances. For example, the peak area for choline (m/z 104.10699 in positive mode) was 1.9 × 109 at 500 K resolution with an AGC target of 5 × 104. The peak area for the same species was 6.4 × 108 at 500 K resolution with an AGC target of 5 × 105, a 66% decrease. When the AGC target setting remained at 5 × 105, reducing the resolution to 120 K increased the peak area to 1.0 × 109, a 56% increase. These results suggest that the choice of high resolution and AGC target settings can result in significant signal loss, introducing changes in the relative quantitation of low abundance metabolites. For the FT-ICR platform, 75 and 93 metabolite species were detected in positive and negative ion modes, respectively. Sixty-five of these were detected in both ion modes. Compared with the Orbitrap dataset, the number of metabolites detected using DI-FT-ICR was comparable in positive mode and higher in negative mode, likely due to the lack of UPLC dilution effects in DI mode and the higher sample volume consumed by the FT-ICR platform. These results should be interpreted with caution, as the UPLC-MS platform is less sensitive to ionization suppression effects than the DI platform, so for more complex samples, the DI platform may detect a lower number of analytes. Detection differences could also be ascribed to the differences in solvents present during the ionization process (UPLC mobile phase vs methanol). A list of detected metabolites is provided in the Supporting Information (Table S1).

Under the various experimental Orbitrap conditions investigated, the absolute mass accuracy for metabolite species was, on average, below 0.5 ppm, except at the 5 × 105 AGC target setting in negative ion mode. This very high mass accuracy is a result of the combined external and internal calibration used in the Orbitrap platform. In agreement with the findings by Barbier Saint Hilaire et al., resolution had little effect on mass accuracy, whereas the highest AGC target setting was observed to have a negative impact.33 Though not observed in positive mode, increasing the AGC target to 5 × 105 increased the mass error to ~0.7–0.9 ppm in negative ion mode. This reduction in mass accuracy was attributed to higher space charge effects with increased ion filling at the higher AGC target setting. Space charge effects are known to affect frequency shifts of ions with adjacent frequencies, resulting in a mass accuracy decrease.42 For FT-ICR, the observed mass accuracy was excellent, reaching ~0.1 ppm in both ion modes and only requiring external calibration. This ultrahigh mass accuracy is primarily a result of the high magnetic field in the ICR cell that minimizes ion cyclotron frequency shifts due to space charge effects.19

C. elegans extract samples with spiked-in metabolite species were analyzed to investigate the impact of a complex biological matrix on accurate mass measurements. The experimental conditions were identical to those used in the experiments described above. The performance of the Orbitrap platform for detecting spiked metabolites in the biological sample was similar to that in the model mixture. A number of metabolites not detected in the model mixture were detected in experiments with the spiked biological sample, likely due to higher ion abundances stemming from endogenous contributions. The Orbitrap mass accuracy was comparable with that for metabolites in model solutions. Mass errors were below 0.5 ppm, except at the 5 × 105 AGC target setting in negative ion mode, where mass errors were in the 0.61–1.13 ppm range. This mass error increase was explained by the added space charge effects in the presence of ions from the more complex biological matrix at such a high AGC target setting. For FT-ICR MS experiments, the average mass error was 0.17 ppm in both ion modes with external calibration, illustrating the excellent performance in detecting metabolites in complex biological matrices. A summary of the mass accuracy results and the number of detected metabolite species in the C. elegans matrix are provided in Table S4.

Evaluation of Relative Isotope Abundance Errors.

As the vast majority of metabolites contain carbon and/or oxygen atoms, RIA measurement of 13C/12C and 18O/16O pairs can provide valuable information for assigning elemental formulas by constraining the number of elemental atoms.32 The ability to resolve isotopic fine structures—for example, distinguishing 18O1 from 13C2—is essential for accurate RIA measurements. In evaluating the accuracy of RIA measurements for the two FTMS platforms, we first identified 13C1 and 18O1 isotopes from the datasets collected under various experimental conditions. For the Orbitrap platform, 45–61 13C1 isotopic signals were detected for the targeted metabolites in positive ion mode under various resolutions and AGC target settings. Due to lower natural abundance of the 18O1 isotope, only 12–29 18O1 isotopic signals were detected under the same conditions. As with monoisotopic ion species, increased AGC target and resolution settings resulted in a reduced number of 13C1 and 18O1 signals, especially for lower abundance ions. For FT-ICR, 55 13C1 and 19 18O1 isotopic signals were detected in positive ion mode. The lower number of detected isotopes with FT-ICR was attributed to the ion suppression effects caused by the DI electrospray sample introduction, whereas UPLC was used for Orbitrap experiments, reducing interferences through chemical separation.43 A similar trend was observed in negative ion mode for the Orbitrap platform; 36–60 13C1 and 8–22 18O1 isotopes were detected, with a lower number of isotopes detected at higher AGC target and resolution settings. Contrary to experiments in positive ion mode, 80 13C1 and 45 18O1 isotopes were detected in negative mode with FT-ICR, more than the species detected with Orbitrap. This was attributed to the higher ionization efficiency of some of the investigated metabolites in negative ion mode that contributed to better detection.

RIA errors were calculated for the detected 13C1 and 18O1 isotopes using eq 2 defined in the experimental section. In agreement with previous findings using Orbitrap MS,32,33 RIA errors for 13C1 isotopes were affected by resolution and varied with peak abundance, whereas AGC target setting had little effect. In positive ion mode, the mean absolute RIA errors for 13C1 isotopes were 6.2, 8.8, and 13.3% at resolution settings of 120, 240, and 500 K, respectively. At 500 K resolution, RIA errors were greatly increased for monoisotopic species with abundances below 1.0 × 106, with the shift mainly toward negative RIA error values. This type of shift has been previously reported32,33,36 and may be explained by the instability of small ion clouds in the Orbitrap.33,44,45 The increased RIA errors could also be attributed to the limitations of AGC to maintain nonequivalent scans consistently during liquid chromatography and the flooring performed by the data acquisition software during Fourier transformation. Therefore, the more intense the monoisotopic ion signal, the more accurate the 13C1 RIA measurement for determining elemental formulas. For FT-ICR, there was no observable correlation between RIA deviation and peak abundance. The mean absolute RIA error value of 13C1 isotopes was 12.2%, which was comparable to the Orbitrap MS platform at 500 K mass resolution. In negative ion mode Orbitrap MS, the mean absolute RIA error values of 13C1 isotopes were 5.8, 10.2, and 13.4% at resolution settings of 120, 240, and 500 K, respectively. FT-ICR MS data generated a mean absolute 13C1 RIA error value of 10.1% in negative ion mode. Higher 13C1 RIA errors were observed for ion species with abundance below 1.0 × 106 at 240 and 500 K resolution with the Orbitrap, whereas FT-ICR data did not exhibit similar RIA deviation trends. RIA errors for 13C1 isotopes under various experimental conditions are illustrated in Figure 1.

Figure 1.

Figure 1.

Orbitrap RIA errors for 13C1 isotopes at 120 K (a, d), 240 K (b, e), and 500 K (c, f) resolution settings; and at ~700 K (g, h) resolution setting using FT-ICR MS. RIA errors of the 13C1 (M + 1) isotopic ions are expressed as a function of the abundance of the corresponding monoisotopic ion (M). For Orbitrap MS, data were collected in positive (a–c) and negative (d–f) ion modes. In all cases, data acquired at different AGC target settings (5 × 104, 1 × 105, and 5 × 105) were combined. For FT-ICR MS, data were collected in positive (g) and negative (h) ion modes. In both ion modes, a transient size of 8 M (~700 K resolution) was used. Mass resolution was defined at FWHM at m/z 200.

RIA measurement errors for 18O1 isotopes were generally higher than those for 13C1 isotopes. Similar trends were reported in previous studies with older Orbitrap instruments.32,33 For the ID-X Orbitrap platform, the mean absolute RIA error values for 18O1 isotopes in positive ion mode across chromatographic peaks were 16.0, 24.5, and 43.8% at resolution settings of 120, 240, and 500 K, respectively. In negative ion mode, the mean absolute RIA errors were 12.5, 18.0, and 30.3% at 120, 240, and 500 K, respectively. Compared with the more abundant 13C1 isotopes, the higher 18O1 RIA errors were caused by the lower isotopic ion abundances. Overall, increasing the resolution setting was observed to lower the quality of RIA measurements. For FT-ICR MS, the mean absolute 18O1 RIA errors across 200 scans were 16.8 and 13.3% in positive and negative ion modes, respectively. RIA errors for 18O1 isotopes in the synthetic standard mixture are provided in the Supporting Information (Figure S1).

The impact of the biological matrix on RIA measurement errors for 13C1 and 18O1 isotopes was also evaluated. For Orbitrap MS, 48–61 and 16–36 13C1 and 18O1 isotopes, respectively, were detected in positive ion mode, with a lower number of detected isotopic species at higher AGC target and resolution settings. The mean absolute 13C1 RIA errors ranged from 4.7 to 8.8%, and 18O1 RIA errors ranged from 12.2 to 30.5%, with increased RIA errors at higher resolution settings. In negative ion mode, 37–70 13C1 and 11–29 18O1 isotopes were detected, with mean absolute 13C1 RIA errors ranging from 7.2 to 13.4%, and 18O1 RIA errors ranging from 11.9 to 30.6%. Compared with standards in model mixtures, the improved number of detected isotope species and RIA errors were attributed to the added abundance of endogenous metabolites in the biological matrix. A list of endogenous metabolites detected in the biological matrix but not detected in model mixtures is given in Table S5. For FT-ICR MS, the results were similar to the standards in neat solvent. In positive ion mode, 57 13C1 and 22 18O1 isotopes were detected, with mean absolute RIA errors of 11.7 and 19.0% for 13C1 and 22 18O1 isotopes, respectively. In negative ion mode, 79 13C1 and 48 18O1 isotopes were detected, with mean absolute RIA errors of 10.2 and 12.8% for 13C1 and 22 18O1 isotopes, respectively. A summary of observed RIA errors for 13C1 and 18O1 isotopes in the C. elegans biological matrix under various experimental conditions is provided in the supporting information section (Figures S2 and S3).

Impact of Mass Accuracy and RIA Measurement on Elemental Formula Assignments.

In evaluating the impact of mass accuracy and RIA errors on elemental formula assignments, we first compared the performance of the two FTMS platforms at similar resolution settings (~500 K at m/z 200 for Orbitrap MS and m/z 400 for FT-ICR MS). We determined an AGC target setting of 1 × 105 as optimal due to the higher AGC setting (5 × 105), resulting in lower mass accuracy and the lower AGC setting (5 × 104), decreasing the overall sensitivity.35 C. elegans extracts with spiked-in metabolites were used for these experiments, as these samples better mimic complex biological samples from a typical metabolomics study. In assigning elemental formulas, a mass error tolerance <3 ppm was used, together with heuristic rules and RDBE restrictions as the filtering criteria. For Orbitrap MS, 94.3% (66 out of 70) and 90.1% (73 out of 81) of metabolites investigated were assigned the correct elemental formula as the top 1 candidate in positive and negative ion modes, respectively. Among those metabolites, 67.1% (47 out of 70) and 66.7% (54 out of 81) had a single correct elemental formula in positive and negative modes, respectively. For FT-ICR MS, 100.0% (77 out of 77) and 92.6% (87 out of 94) of metabolites were assigned the correct elemental formula in positive and negative ion modes, respectively. Of these, 68.8% (53 out of 77) and 67.0% (63 out of 94) only had a single candidate elemental formula in positive and negative ion modes, respectively.

Starting at m/z 225, more than one candidate elemental formulas can be generated within a 0.001 m/z or 3 ppm mass error threshold; from m/z 285, the number of candidate elemental formulas exceeds 10. Though accurate mass measurements allow the assignment of correct elemental formulas as the top candidate in most cases, further filtering criteria are needed to reduce such numbers and increase confidence in the assignments.

RIA for 13C1 isotopes was then applied as the second filtering criterion to elemental formula elucidation. The number of carbon atoms (no.Cexp) was calculated based on 13C1 RIA using eq 2 and the no.Cexp ± 1 was used to filter elemental formula candidates. Using 13C1 RIA as a filter, the number of candidate elemental formulas was greatly reduced, and the success of elemental formula assignment greatly improved. Using RIA filtering for Orbitrap MS data, 97.1 (68 out of 70) and 93.4% (76 out of 81) of metabolites investigated were assigned the correct elemental formulas in positive and negative ion modes, respectively. Among those metabolites, 71.4 (50 out of 70) and 75.3% (61 out of 81) had only a single correct elemental formula assignment in positive and negative modes, respectively. For FT-ICR MS, 100.0 (77 out of 77) and 95.7% (90 out of 94) of metabolites were assigned the correct elemental formula, and 76.6 (59 out of 77) and 79.8% (75 out of 94) were assigned a single correct elemental formula in positive and negative ion modes, respectively.

Though RIA for 18O1 isotopes was generally less accurate than for 13C1 isotopes, their application could still help determine the best candidate elemental formulas. The number of oxygen atoms (no.Oexp) was calculated, and no.Oexp ± 1, when available, was used to further filter elemental formula candidates. Due to the limited number of detected 18O1 isotopes, the improvement on elemental formula assignment was limited for Orbitrap datasets. In positive ion mode, 97.1% (68 out of 70) of metabolites investigated were assigned the correct elemental formula, with 74.3% (52 out of 70) metabolites having a single correct elemental formula assignment. Results remained unchanged for the negative mode dataset. For FT-ICR MS, the performance of elemental formula assignment improved, especially in negative ion mode. 100.0 (77 out of 77) and 97.9% (92 out of 94) of metabolites were assigned the correct elemental formula, among which 79.2 (61 out of 77) and 89.4% (84 out of 94) had a single correct formula in positive and negative ion modes, respectively. This improvement was attributed to more detected 18O1 isotopes and relatively more reliable RIA measurements using FT-ICR MS. A summary of elemental formula assignments with various filtering criteria under different experimental conditions is shown in Figure 2.

Figure 2.

Figure 2.

Summary of elemental formula assignment with various filtering criteria (mass accu.: only a mass error threshold of <0.001 m/z or 3 ppm was applied; add C13: add no.Cexp ± 1 filter based on 13C1 RIA calculation; add O18: further apply no.Oexp ± 1 based on 18O1 RIA calculation). Data were collected using Orbitrap MS in positive (a) and negative (b) ion modes and FT-ICR MS in positive (c) and negative (d) ion modes. For Orbitrap MS, 500 K resolution and an AGC target of 1 × 105 were used. For FT-ICR MS, 8 M transient size and 0.025 s accumulation time were used. ESI: electrospray ionization; NI: not identified or correct elemental formula was not listed in the top 3 candidates; top 3/multiple: correct elemental formulas were listed in top 3 candidates with multiple assignments; 1/multiple: assigned with correct elemental formula as the top 1 candidate with multiple assignments; and 1/single: a single correct formula assignment.

As higher resolution was observed to negatively affect RIA accuracy and sensitivity with the Orbitrap platform, we also evaluated elemental formula assignment performance using the same criteria but at lower resolution settings (120 and 240 K, 1 × 105 AGC target). A summary of elemental formula assignment results at different resolution settings with the Orbitrap MS system is given in Figure 3. Contrary to expectations, the performance of elemental formula assignment at 120 K resolution was better than at 240 K. Though the percentage of correctly identified metabolites was highest at 500 K, it should be noted that the number of detected metabolites species was lower at 500 K than at 120 and 240 K (in positive ion mode: 120 K: 72, 240 K: 72, 500 K: 70; in negative ion mode: 120 K: 88, 240 K: 86, 500 K: 81). These results were attributed to the reduction in signal abundances at higher resolution settings, as previously observed. However, lower resolution at 120 and 240 K was not sufficient for discriminating other minor isotopic signals, such as 13C2 and 18O1 at m/z above 250 and 350, respectively,33 which can cause inaccurate 18O1 RIA measurements.0

Figure 3.

Figure 3.

Summary of elemental formula assignment results with Orbitrap MS at 120 K (a, b), 240 K (c, d), and 500 K (e, f) resolution settings. Data were collected in positive (a, c, e) and negative (b, d, f) ion modes. In all cases, the AGC target setting of 1 × 105 was used.

Taken together, the optimal experimental settings for the Orbitrap MS platform were a resolution setting of 240 K and AGC target at 1 × 105 for detection and identification purposes. As the m/z values of the majority of the metabolites tested were below 350, this resolution setting was sufficient for separating minor isotopes such as 13C2 and 18O1 and sensitive enough for detecting the investigated metabolites with excellent performance for elemental formula elucidation. At 500 K resolution, the performance for correct elemental formula assignment appeared to be comparable, even with increased RIA errors. However, caution should be exercised in terms of the possibility of signal loss and higher RIA errors for less abundant species. For the FT-ICR MS platform, high performance in assigning the correct elemental formula as the top 1 candidate (100% in positive ion mode and 92.5% in negative ion mode) can be achieved solely based on its ultrahigh mass accuracy. Addition of RIA information further enhanced annotation performance due to the relatively lower RIA errors while still maintaining high resolving power. These results suggest that, whenever possible, the use of both platforms in combination may offer the best results in terms of coverage and identification.

CONCLUSIONS

Mass accuracy and 13C1 and 18O1 RIA measurements produced by high-field Orbitrap ID-X and 12T solariX FT-ICR platforms were evaluated in the context of elemental formula assignments in metabolomics. A total of 104 metabolites were tested in neat solvent and a complex biological extract matrix. For the Orbitrap MS platform, high mass accuracy (<1 ppm) was achieved with the combination of internal and external calibration. Results indicated that high resolution (500 K) and AGC target (5 × 105) settings resulted in higher mass errors and a lower number of detected metabolite species. At the 500 K resolution setting, RIA errors greatly increased for metabolites with lower abundance (<1.0 × 106). Therefore, it is recommended that 240 K resolution and 1 × 105 AGC target settings are used for general non-targeted metabolomics studies with lower molecular weight metabolites. When higher resolving power is needed, as with very complex mixtures, or when near-isobaric spectral interferences might be present, caution should be taken with RIA accuracies for low abundance species due to the associated signal losses. For the 12 T FT-ICR MS platform, ultrahigh mass accuracy (<0.2 ppm) was obtained using external calibration, together with high performance in assigning the correct elemental formula as the top 1 candidate solely based on accurate mass measurements. This performance, however, was achieved at the expense of slower spectral acquisition rates (~1 Hz). Reliable RIA measurements for 13C1 and 18O1 isotopes were obtained while maintaining high resolving power. For both tested platforms, 13C1 and 18O1 RIA measurements could improve annotation performance by reducing the number of candidate elemental formulas. To further utilize the advantages of the test platforms, UPLC-Orbitrap MS could be firstly applied for fast metabolic profiling of the samples; fractions of interested metabolites could then be infused into the FT-ICR MS platform for obtaining enhanced isotopic fine structures using its ultrahigh resolving power. Taken together, our study provides a systematic evaluation of two of the most advanced FTMS analytical platforms currently used in metabolomics studies.

Supplementary Material

Supporting Information

ACKNOWLEDGMENTS

F.M.F. acknowledges support by NIH 1U2CES030167 and 1R01CA218664-01. F.M.F. also acknowledges support from NSF MRI CHE-1726528 Grant for the acquisition of an ultrahigh resolution Fourier transform ion cyclotron resonance (FTICR) mass spectrometer for the Georgia Institute of Technology core facilities. We thank Art Edison for coordinating this overall project. Amanda Shaver and Gonçalo Gouveia provided C. elegans samples. This work was supported by Georgia Institute of Technology’s Systems Mass Spectrometry Core Facility.

Footnotes

Supporting Information

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.analchem.1c02224.

Detailed experimental parameters and additional results, including information on standard compounds, the gradient program used for chromatographic separations, MS parameter settings, mass accuracy and the number of detected metabolite species in a C. elegans biological matrix, RIA errors for 18O1 isotopes under various experimental conditions, list of endogenous metabolites in C. elegans biological matrix, and a summary of RIA 13C1 and 18O1 isotope errors in the C. elegans biological matrix are provided (PDF)

Complete contact information is available at: https://pubs.acs.org/10.1021/acs.analchem.1c02224

The authors declare no competing financial interest.

Contributor Information

Danning Huang, School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, United States;.

Marcos Bouza, School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, United States;.

David A. Gaul, School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, United States

Franklin E. Leach, III, Department of Environmental Health Science, University of Georgia, Athens, Georgia 30602, United States;.

I. Jonathan Amster, Department of Chemistry, University of Georgia, Athens, Georgia 30602, United States;.

Frank C. Schroeder, Boyce Thompson Institute and Department to Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, United States;.

Arthur S. Edison, Departments of Genetics and Biochemistry and Molecular Biology, Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia 30602, United States;.

Facundo M. Fernández, School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, United States;.

REFERENCES

  • (1).Gowda GA; Djukovic D Methods Mol. Biol 2014, 1198, 3–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (2).Dunn WB; Erban A; Weber RJM; Creek DJ; Brown M; Breitling R; Hankemeier T; Goodacre R; Neumann S; Kopka J; Viant MR Metabolomics 2013, 9, 44–66. [Google Scholar]
  • (3).Wishart D; Feunang Y; Marcu A; Guo A; Liang K; Vazquez-Fresno R; Sajed T; Johnson D; Li C; Karu N; Sayeeda Z; Lo E; Assempour N; Berjanskii M; Singhal S; Arndt D; Liang Y; Badran H; Grant J; Serra-Cayuela A; Liu Y; Mandal R; Neveu V; Pon A; Knox C; Wilson M; Manach C; Scalbert A Nucleic Acids Res. 2018, 46, D608–D617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (4).Guijas C; Montenegro-Burke J; Domingo-Almenara X; Palermo A; Warth B; Hermann G; Koellensperger G; Huan T; Uritboonthai W; Aisporna A; Wolan D; Spilker M; Benton H; Siuzdak G Anal. Chem 2018, 90, 3156–3164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (5).Fahy E; Sud M; Cotter D; Subramaniam S Nucleic Acids Res. 2007, 35, W606–W612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (6).Kind T; Liu KH; Lee DY; DeFelice B; Meissen JK; Fiehn O Nat. Methods 2013, 10, 755–758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (7).Wolf S; Schmidt S; Muller-Hannemann M; Neumann S BMC Bioinf. 2010, 11, No. 148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (8).Zhou ZW; Shen XT; Tu J; Zhu ZJ Anal. Chem 2016, 88, 11084–11091. [DOI] [PubMed] [Google Scholar]
  • (9).Groessl M; Graf S; Knochenmuss R Analyst 2015, 140, 6904–6911. [DOI] [PubMed] [Google Scholar]
  • (10).Schrimpe-Rutledge AC; Codreanu SG; Sherrod SD; McLean JA J. Am. Soc. Mass Spectrom 2016, 27, 1897–1905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (11).Pluskal T; Uehara T; Yanagida M Anal. Chem 2012, 84, 4396–4403. [DOI] [PubMed] [Google Scholar]
  • (12).Kind T; Fiehn O BMC Bioinf. 2007, 8, No. 105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (13).Brown S; Kruppa G; Dasseux J Mass Spectrom. Rev 2005, 24, 223–231. [DOI] [PubMed] [Google Scholar]
  • (14).Hu Q; Noll R; Li H; Makarov A; Hardman M; Cooks RJ Mass Spectrom. 2005, 40, 430–443. [DOI] [PubMed] [Google Scholar]
  • (15).Junot C; Madalinski G; Tabet J; Ezan E Analyst 2010, 135, 2203–2219. [DOI] [PubMed] [Google Scholar]
  • (16).Ghaste M; Mistrik R; Shulaev V Int. J. Mol. Sci 2016, 17, No. 816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (17).Scigelova M; Hornshaw M; Giannakopulos A; Makarov A Mol. Cell. Proteomics 2011, 10, No. M111.009431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (18).Eliuk S; Makarov A Annu. Rev. Anal. Chem 2015, 8, 61–80. [DOI] [PubMed] [Google Scholar]
  • (19).Hendrickson CL; Quinn JP; Kaiser NK; Smith DF; Blakney GT; Chen T; Marshall AG; Weisbrod CR; Beu SC J. Am. Soc. Mass Spectrom 2015, 26, 1626–1632. [DOI] [PubMed] [Google Scholar]
  • (20).Kind T; Fiehn O BMC Bioinf. 2006, 7, No. 234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (21).Ohta D; Kanaya S; Suzuki H Curr. Opin. Biotechnol 2010, 21, 35–44. [DOI] [PubMed] [Google Scholar]
  • (22).Moseley HNB BMC Bioinf. 2010, 11, No. 139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (23).Nagornov KO; Gorshkov MV; Kozhinov AN; Tsybin YO Anal. Chem 2014, 86, 9020–9028. [DOI] [PubMed] [Google Scholar]
  • (24).Park SG; Anderson GA; Bruce JE J. Am. Soc. Mass Spectrom 2020, 31, 719–726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (25).Witting M; Lucio M; Tziotis D; Wagele B; Suhre K; Voulhoux R; Garvis S; Schmitt-Kopplin P Anal. Bioanal. Chem 2015, 407, 1059–1073. [DOI] [PubMed] [Google Scholar]
  • (26).Kirwan JA; Broadhurst DI; Davidson RL; Viant MR Anal. Bioanal. Chem 2013, 405, 5147–5157. [DOI] [PubMed] [Google Scholar]
  • (27).Han J; Danell RM; Patel JR; Gumerov DR; Scarlett CO; Speir JP; Parker CE; Rusyn I; Zeisel S; Borchers CH Metabolomics 2008, 4, 128–140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (28).Makarov A; Scigelova MJ Chromatogr. A 2010, 1217, 3938–3945. [DOI] [PubMed] [Google Scholar]
  • (29).Bonte R; Bongaerts M; Demirdas S; Langendonk JG; Huidekoper HH; Williams M; Onkenhout W; Jacobs EH; Blom HJ; Ruijter GJG Metabolites 2019, 9, No. 289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (30).Makarov A; Denisov E; Lange OJ Am. Soc. Mass Spectrom 2009, 20, 1391–1396. [DOI] [PubMed] [Google Scholar]
  • (31).Knolhoff AM; Callahan JH; Croley TR J. Am. Soc. Mass Spectrom 2014, 25, 1285–1294. [DOI] [PubMed] [Google Scholar]
  • (32).Xu Y; Heilier J; Madalinski G; Genin E; Ezan E; Tabet J; Junot C Anal. Chem 2010, 82, 5490–5501. [DOI] [PubMed] [Google Scholar]
  • (33).Barbier Saint Hilaire P; Hohenester U; Colsch B; Tabet J; Junot C; Fenaille F Anal. Chem 2018, 90, 3030–3035. [DOI] [PubMed] [Google Scholar]
  • (34).Mitchell JM; Flight RM; Moseley HN B. Anal. Chem 2019, 91, 8933–8940. [DOI] [PubMed] [Google Scholar]
  • (35).Thompson CJ; Witt M; Forcisi S; Moritz F; Kessler N; Laukien FH; Schmitt-Kopplin PJ Am. Soc. Mass Spectrom 2020, 31, 2025–2034. [DOI] [PubMed] [Google Scholar]
  • (36).Weber R; Southam A; Sommer U; Viant M Anal. Chem 2011, 83, 3737–3743. [DOI] [PubMed] [Google Scholar]
  • (37).Zhu JJ; Djukovic D; Deng LL; Gu HW; Himmati F; Chiorean EG; Raftery DJ Proteome Res. 2014, 13, 4120–4130. [DOI] [PubMed] [Google Scholar]
  • (38).Pluskal T; Castillo S; Villar-Briones A; Oresic M BMC Bioinf. 2010, 11, No. 395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (39).Pluskal T; Korf A; Smirnov A; Schmid R; Fallon TR; Du XX; Weng JK Metabolomics Data Analysis Using MZmine. Processing Metabolomics and Proteomics Data with Open Software: A Practical Guide; Royal Society of Chemistry, 2020; Vol. 8, pp 232–254. [Google Scholar]
  • (40).Chambers MC; Maclean B; Burke R; Amodei D; Ruderman DL; Neumann S; Gatto L; Fischer B; Pratt B; Egertson J; Hoff K; Kessner D; Tasman N; Shulman N; Frewen B; Baker TA; Brusniak MY; Paulse C; Creasy D; Flashner L; Kani K; Moulding C; Seymour SL; Nuwaysir LM; Lefebvre B; Kuhlmann F; Roark J; Rainer P; Detlev S; Hemenway T; Huhmer A; Langridge J; Connolly B; Chadick T; Holly K; Eckels J; Deutsch EW; Moritz RL; Katz JE; Agus DB; MacCoss M; Tabb DL; Mallick P Nat. Biotechnol 2012, 30, 918–920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (41).Mol HGJ; Tienstra M; Zomer P Anal. Chim. Acta 2016, 935, 161–172. [DOI] [PubMed] [Google Scholar]
  • (42).Perry RH; Cooks RG; Noll RJ Mass Spectrom. Rev 2008, 27, 661–699. [DOI] [PubMed] [Google Scholar]
  • (43).Annesley T Clin. Chem 2003, 49, 1041–1044. [DOI] [PubMed] [Google Scholar]
  • (44).Ilchenko S; Previs SF; Rachdaoui N; Willard B; McCullough AJ; Kasumov TJ Am. Soc. Mass Spectrom 2013, 24, 309–312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (45).Southam AD; Payne TG; Cooper HJ; Arvanitis TN; Viant MR Anal. Chem 2007, 79, 4595–4602. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

RESOURCES